RESPICHLOR 15% w/w Oral Powder

País: Irlanda

Língua: inglês

Origem: HPRA (Health Products Regulatory Authority)

Ingredientes ativos:

Chlortetracycline hydrochloride

Disponível em:

Interchem Ireland Ltd

Código ATC:

QJ01AA03

DCI (Denominação Comum Internacional):

Chlortetracycline hydrochloride

Dosagem:

150 milligram(s)/gram

Forma farmacêutica:

Oral powder

Tipo de prescrição:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupo terapêutico:

Cattle

Área terapêutica:

chlortetracycline

Indicações terapêuticas:

Antibacterial

Status de autorização:

Authorised

Data de autorização:

2001-06-29

Características técnicas

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
RESPICHLOR 15% w/w Oral Powder.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains
Active substance
Chlortetracycline hydrochloride
150 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral Powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves (less than 6 months of age).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated as an aid in the treatment of respiratory
disease in calves caused by_ Pasteurella spp_., sensitive
to chlortetracycline.
4.3 CONTRAINDICATIONS
Do not use in adult ruminants, dairy cows and veal calves.
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_1_
_1_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_9_
_7_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Ideally, use of the product should be based on susceptibility testing.
Inappropriate use of the product may increase the prevalence of
bacteria resistant to chlortetracycline and may decrease
the effectiveness of treatment with related substances, due to the
potential for cross-resistance.
To ensure the correct dosage and to avoid possible under-dosing, the
bodyweight should be determined as accurately as
possible
SPECIAL PRECAUTIONS TO BE TAKEN BY